• LeonaBio held its annual shareholder meeting on June 22, 2026.
• Shareholders backed the board’s slate of director nominees, setting terms running until the 2029 annual meeting.
• Ernst & Young LLP was ratified as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.
• Investors endorsed a three-year cycle for future advisory votes on named executive officer pay; the company plans to hold the vote every three years.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LeonaBio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-279425), on June 23, 2026, and is solely responsible for the information contained therein.